Status:
COMPLETED
Antibiotic Elution After Two-stage Knee Revision
Lead Sponsor:
University Hospital, Bonn
Conditions:
Periprosthetic Knee Infection
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to monitor the eluted antibiotic concentrations of gentamicin and vancomycin by a static knee cement spacer in patients being treated for periprosthetic infecti...
Detailed Description
The present study moinitors antibiotic concentrations eluted by a static cement knee spacer as two-stage revision treatment of a knee PJI. The static cement spacer consists of COPAL G+V cement contain...
Eligibility Criteria
Inclusion
- clinical indication for a two-staged revision of a knee PJI
- approval for surgery by the orthopedic and anesthesiologic departments
- being over 18 years of age
- written, informed consent after detailed patient information about the study protocol and possible study-dependent risks
Exclusion
- known allergies to the antibiotics gentamicin and vancomycin contained in the spacer
Key Trial Info
Start Date :
January 31 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 20 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06944184
Start Date
January 31 2024
End Date
July 20 2024
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bonn
Bonn, North Rhine-Westphalia, Germany, 53127